0001013594-24-000191.txt : 20240214 0001013594-24-000191.hdr.sgml : 20240214 20240214161316 ACCESSION NUMBER: 0001013594-24-000191 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 EFFECTIVENESS DATE: 20240214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lion Point Capital, LP CENTRAL INDEX KEY: 0001643354 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1230 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-17316 FILM NUMBER: 24638275 BUSINESS ADDRESS: STREET 1: 250 WEST 55TH STREET STREET 2: 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-356-6200 MAIL ADDRESS: STREET 1: 250 WEST 55TH STREET STREET 2: 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE 0001643354 XXXXXXXX 12-31-2023 12-31-2023 false Lion Point Capital, LP
250 WEST 55TH STREET 33RD FLOOR NEW YORK NY 10019
13F HOLDINGS REPORT 028-17316 000174322 801-81004 N
Irshad Karim General Counsel and Chief Compliance Officer 212-356-6200 /s/ Irshad Karim New York NY 02-14-2024 0 30 199864988
INFORMATION TABLE 2 informationtable.xml AADI BIOSCIENCE INC COM 00032Q104 166494 82423 SH SOLE 82423 0 0 ACLARIS THERAPEUTICS INC COM 00461U105 121693 115898 SH SOLE 115898 0 0 ALPHABET INC CAP STK CL C 02079K107 14093 100 SH SOLE 100 0 0 AMYLYX PHARMACEUTICALS INC COM 03237H101 206080 14000 SH SOLE 14000 0 0 ARDELYX INC COM 039697107 7140335 1151667 SH SOLE 1151667 0 0 AVADEL PHARMACEUTICALS PLC SPONSORED ADR 05337M104 1129600 80000 SH SOLE 80000 0 0 BATTALION OIL CORPORATION COM 07134L107 2135169 222182 SH SOLE 222182 0 0 BLUEBIRD BIO INC COM 09609G100 733133 531256 SH SOLE 531256 0 0 BURGERFI INTERNATIONAL INC COM 12122L101 2361232 2745938 SH SOLE 2745938 0 0 BURGERFI INTERNATIONAL INC *W EXP 12/16/202 12122L119 93755 2083438 SH SOLE 2083438 0 0 CYMABAY THERAPEUTICS INC COM 23257D103 1946879 82425 SH SOLE 82425 0 0 ENPHYS ACQUISITION CORP CL A ORD SHS G3167L109 833594 78125 SH SOLE 78125 0 0 FENNEC PHARMACEUTICALS INC COM 31447P100 1234200 110000 SH SOLE 110000 0 0 HARPOON THERAPEUTICS INC COM NEW 41358P205 2602593 228900 SH SOLE 228900 0 0 HUMACYTE INC COM 44486Q103 667400 235000 SH SOLE 235000 0 0 INSMED INC COM PAR $.01 457669307 2179682 70335 SH SOLE 70335 0 0 ISHARES TR RUSSELL 2000 ETF 464287655 33117150 165000 SH Put SOLE 165000 0 0 KINIKSA PHARMACEUTICALS LTD COM CL A G5269C101 2292320 130691 SH SOLE 130691 0 0 LUMOS PHARMA INC COM 55028X109 288725 90794 SH SOLE 90794 0 0 MARINUS PHARMACEUTICALS INC COM NEW 56854Q200 23200243 2134337 SH SOLE 2134337 0 0 MICROSOFT CORP COM 594918104 37604 100 SH SOLE 100 0 0 MILESTONE PHARMACEUTICALS IN COM 59935V107 2755846 1650207 SH SOLE 1650207 0 0 MIRUM PHARMACEUTICALS INC COM 604749101 398520 13500 SH SOLE 13500 0 0 REPLIMUNE GROUP INC COM 76029N106 358275 42500 SH SOLE 42500 0 0 SEMTECH CORP COM 816850101 56480803 2577855 SH SOLE 2577855 0 0 SEMTECH CORP COM 816850101 54775000 2500000 SH Call SOLE 2500000 0 0 SERES THERAPEUTICS INC COM 81750R102 477065 340761 SH SOLE 340761 0 0 SYNDAX PHARMACEUTICALS INC COM 87164F105 745545 34500 SH SOLE 34500 0 0 TRAVERE THERAPEUTICS INC COM 89422G107 701220 78000 SH SOLE 78000 0 0 TRAVERE THERAPEUTICS INC NOTE 2.250% 3/0 89422GAA5 670740 1000000 PRN SOLE 1000000 0 0